ATM mutations in patients with hereditary pancreatic cancer.

Author(s): Roberts NJ,  Jiao Y,  Yu J,  Kopelovich L,  Petersen GM,  Bondy ML,  Gallinger S,  Schwartz AG,  Syngal S,  Cote ML,  Axilbund J,  Schulick R,  Ali SZ,  Eshleman JR,  Velculescu VE,  Goggins M,  Vogelstein B,  Papadopoulos N,  Hruban RH,  Kinzler KW,  Klein AP

Journal: Cancer Discov

Date: 2012 Jan

Major Program(s) or Research Group(s): CADRG

PubMed ID: 22585167

PMC ID: PMC3676748

Abstract: UNLABELLED: Pancreatic cancers are the fourth most-common cause of cancer-related deaths in the Western world, with >200,000 cases reported in 2010. Although up to 10% of these cases occur in familial patterns, the hereditary basis for predisposition in the vast majority of affected families is unknown. We used next-generation sequencing, including whole-genome and whole-exome analyses, and identified heterozygous, constitutional, ataxia telangiectasia mutated (ATM) gene mutations in 2 kindreds with familial pancreatic cancer. Mutations segregated with disease in both kindreds and tumor analysis demonstrated LOH of the wild-type allele. By using sequence analysis of an additional 166 familial pancreatic cancer probands, we identified 4 additional patients with deleterious mutations in the ATM gene, whereas we identified no deleterious mutations in 190 spouse controls (P = 0.046). When we considered only the mostly severely affected families with 3 or more pancreatic cancer cases, 4 deleterious mutations were found in 87 families (P = 0.009). Our results indicate that inherited ATM mutations play an important role in familial pancreatic cancer predisposition. SIGNIFICANCE: The genes responsible for the majority of cases of familial pancreatic ductal adenocarcinoma are unknown. We here identify ATM as a predisposition gene for pancreatic ductal adenocarcinoma. Our results have important implications for the management of patients in affected families and illustrate the power of genome-wide sequencing to identify the basis of familial cancer syndromes.